Please login to the form below
Transgene
This page shows the latest Transgene news and features for those working in and with pharma, biotech and healthcare.
Novartis and Precision BioSciences announce in vivo gene editing collaboration
As part of the agreement, Precision will develop a custom ARCUS nuclease designed to insert, in vivo, a therapeutic transgene at a “safe harbour” location in the genome as a potential
Latest news
-
Transgene slumps as viral cancer therapy fails phase 3 trial
French biotech Transgene has abandoned a phase 3 trial of its SillaJen-partnered liver cancer therapy after an interim analysis suggested almost no chance of a positive outcome. ... Transgene said in a statement that South Korean biotech SillaJen had
-
AZ invests more in IO with Transgene oncolytic virus deal
However this candidate is based on Transgene’s proprietary next-generation viral platform. ... AstraZeneca has similar plans to combined Transgene’s oncolytic viruses withits in-house pipeline ofImmuno-oncology (IO) treatments.
-
Developing therapeutic cancer vaccines
Both vectors contain the transgenes for PSA and multiple T-cell co-stimulatory molecules.
-
Sanofi to act as contract manufacturer for Transgene
Sanofi has formed an innovative collaboration with fellow French company Transgene that will see it act at the biotech's contract manufacturing organisation (CMO). ... But in return for its investment Transgene will be its preferred customer for 15 years
-
Regional plans
As part of the Institut Merieux group, Transgene would be well placed to be able to address the European market with JX 594 for the treatment of solid tumours. ... 181. Transgene/Jennerex ##. JX 594 for the treatment of solid tumours.
More from news
Approximately 3 fully matching, plus 9 partially matching documents found.
Latest Intelligence
-
Cancer immunotherapy: What's on the horizon?
Other oncolytic viruses are coming through the pipeline, including SillaJen/Transgene’s Pexa-Vec for liver cancer and other solid tumours with trial results due between now and the end of
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- My journey advancing the science in pulmonary hypertension
- NHS App to revolutionise digital health and care with major digital updates by 2023
- A new era for UK-Japanese scientific research relations
- Innovative Health Initiative launches first two calls for proposals to tackle ‘biggest’ health research challenges
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- New Omicron sub-variants cause COVID-19 cases to rise in the UK
- Novartis announces positive phase 3 trial results for advanced oesophageal cancer
- Sanofi Global Health unveils new nonprofit Impact brand
- Pfizer announces commitment to achieve Net-Zero Standard by 2040
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- A creative awakening – how pharma is bringing innovation to the patient journey
- Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
- My journey advancing the science in pulmonary hypertension
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Delivering content to fuel omnichannel engagement
PMHub
Page & Page and Partners
For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
